JP, N., S, M., JD, A., C, A., E, D., R, S., . . . PH, K. (2023). Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: A multicenter phase 2 study. Blood, 142(9), 794. https://doi.org/10.1182/blood.2022018669
Chicago Style (17th ed.) CitationJP, Nicolay, et al. "Dimethyl Fumarate Treatment in Relapsed and Refractory Cutaneous T-cell Lymphoma: A Multicenter Phase 2 Study." Blood 142, no. 9 (2023): 794. https://doi.org/10.1182/blood.2022018669.
MLA (9th ed.) CitationJP, Nicolay, et al. "Dimethyl Fumarate Treatment in Relapsed and Refractory Cutaneous T-cell Lymphoma: A Multicenter Phase 2 Study." Blood, vol. 142, no. 9, 2023, p. 794, https://doi.org/10.1182/blood.2022018669.
Warning: These citations may not always be 100% accurate.
